Benjamin H. Lok

3.6k total citations
76 papers, 2.1k citations indexed

About

Benjamin H. Lok is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Benjamin H. Lok has authored 76 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Benjamin H. Lok's work include Lung Cancer Research Studies (33 papers), Head and Neck Cancer Studies (16 papers) and PARP inhibition in cancer therapy (13 papers). Benjamin H. Lok is often cited by papers focused on Lung Cancer Research Studies (33 papers), Head and Neck Cancer Studies (16 papers) and PARP inhibition in cancer therapy (13 papers). Benjamin H. Lok collaborates with scholars based in United States, Canada and United Kingdom. Benjamin H. Lok's co-authors include Charles M. Rudin, John T. Poirier, Simon N. Powell, J. Laird, Joshua K. Sabari, Elisa de Stanchina, Valentina E. Schneeberger, Nadeem Riaz, Ai Ni and Natasha Rekhtman and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Benjamin H. Lok

69 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin H. Lok United States	22	1.3k	1.0k	479	467	254	76	2.1k
Rahul Ladwa Australia	16	986 0.7×	525 0.5×	365 0.8×	146 0.3×	156 0.6×	93	1.7k
Fan Jin United States	23	1.2k 0.9×	657 0.6×	518 1.1×	144 0.3×	456 1.8×	75	2.2k
Simon J. Dovedi United Kingdom	24	2.0k 1.5×	416 0.4×	578 1.2×	109 0.2×	308 1.2×	60	2.8k
Seija Grénman Finland	16	768 0.6×	631 0.6×	139 0.3×	454 1.0×	282 1.1×	26	2.1k
Benedicte Parm Ulhøi Denmark	27	511 0.4×	856 0.8×	445 0.9×	138 0.3×	800 3.1×	66	2.1k
Peihong Wu China	31	953 0.7×	442 0.4×	726 1.5×	359 0.8×	699 2.8×	124	2.7k
Changhu Chen United States	22	696 0.5×	1.0k 1.0×	1.1k 2.2×	185 0.4×	509 2.0×	40	3.0k
Ani Sarkis Balmanoukian United States	31	2.9k 2.2×	399 0.4×	1.1k 2.3×	153 0.3×	538 2.1×	74	3.5k
Suzanne Russo United States	22	883 0.7×	658 0.6×	626 1.3×	135 0.3×	231 0.9×	73	1.7k
J. Doyen France	22	716 0.5×	520 0.5×	661 1.4×	157 0.3×	294 1.2×	101	1.9k

Countries citing papers authored by Benjamin H. Lok

Since Specialization

Citations

This map shows the geographic impact of Benjamin H. Lok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin H. Lok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin H. Lok more than expected).

Fields of papers citing papers by Benjamin H. Lok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin H. Lok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin H. Lok. The network helps show where Benjamin H. Lok may publish in the future.

Co-authorship network of co-authors of Benjamin H. Lok

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin H. Lok. A scholar is included among the top collaborators of Benjamin H. Lok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin H. Lok. Benjamin H. Lok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Tirth, Mattea Welch, Xiang Y. Ye, et al.. (2025). Association of artificial intelligence-screened interstitial lung disease with radiation pneumonitis in locally advanced non-small cell lung cancer. Radiotherapy and Oncology. 212. 111144–111144. 1 indexed citations

Mighton, Chloe, Katrina Hueniken, Vivek M. Philip, et al.. (2025). Pathogenic germline variants in small cell lung cancer: A systematic review and meta-analysis. Human Genetics and Genomics Advances. 6(3). 100445–100445.

Dong, Songtao, Shannon J. Tsai, Yue Xu, et al.. (2025). A modular mRNA platform for programmable induction of tumour-specific immunogenic cell death. Nature Nanotechnology. 20(12). 1856–1870.

Sacdalan, Danielle Benedict, et al.. (2024). Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications. Current Oncology. 31(1). 482–500. 9 indexed citations

Li, Janice J.N., Geoffrey Liu, & Benjamin H. Lok. (2024). Cell-Free DNA Hydroxymethylation in Cancer: Current and Emerging Detection Methods and Clinical Applications. Genes. 15(9). 1160–1160. 1 indexed citations

Lok, Benjamin H., Andrea Bezjak, Srinivas Raman, et al.. (2024). Phase I Trial of Concurrent Talazoparib and Consolidative Thoracic Radiotherapy for Patients with Extensive-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). S93–S94.

Erickson, Anders W., Ines B. Menjak, Benjamin H. Lok, et al.. (2024). Brain metastasis burden and management in patients with small cell lung cancer in Canada: a retrospective, population-based cohort study. EClinicalMedicine. 77. 102871–102871. 2 indexed citations

Erickson, Anders W., Manmeet S. Ahluwalia, Minesh P. Mehta, et al.. (2023). Prophylactic cranial irradiation in small cell lung cancer patients in the era of magnetic resonance imaging: A systematic review and meta-analysis.. Journal of Clinical Oncology. 41(16_suppl). e20636–e20636. 1 indexed citations

Song, Lifang, Kevin C. Nixon, Vivek M. Philip, et al.. (2023). CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1308–1314. 5 indexed citations

10.

Hueniken, Katrina, Ali Vedadi, M. Catherine Brown, et al.. (2021). Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data. Clinical Lung Cancer. 23(2). e154–e164. 3 indexed citations

11.

Rostami, Ariana, et al.. (2020). The Utility of Liquid Biopsies in Radiation Oncology. International Journal of Radiation Oncology*Biology*Physics. 107(5). 873–886. 15 indexed citations

12.

Fares, Aline Fusco, Benjamin H. Lok, Tong Zhang, et al.. (2020). ALK-rearranged lung adenocarcinoma transformation into high-grade large cell neuroendocrine carcinoma: Clinical and molecular description of two cases. Lung Cancer. 146. 350–354. 14 indexed citations

13.

Laird, J., Benjamin H. Lok, Brandon Carney, et al.. (2019). Positron-Emission Tomographic Imaging of a Fluorine 18–Radiolabeled Poly(ADP-Ribose) Polymerase 1 Inhibitor Monitors the Therapeutic Efficacy of Talazoparib in SCLC Patient–Derived Xenografts. Journal of Thoracic Oncology. 14(10). 1743–1752. 16 indexed citations

14.

Laird, J., Benjamin H. Lok, Jennifer Ma, et al.. (2018). Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts. Clinical Cancer Research. 24(20). 5143–5152. 55 indexed citations

15.

Ma, Jennifer, Benjamin H. Lok, Jingfeng Zong, et al.. (2018). Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot. International Journal of Particle Therapy. 4(4). 10–19. 9 indexed citations

16.

Gardner, Eric E., Benjamin H. Lok, Valentina E. Schneeberger, et al.. (2017). Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis. Cancer Cell. 31(2). 286–299. 347 indexed citations

17.

Lok, Benjamin H., Eric E. Gardner, Valentina E. Schneeberger, et al.. (2016). PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. Clinical Cancer Research. 23(2). 523–535. 261 indexed citations

18.

Gutiontov, Stanley I., Jonathan E. Leeman, Benjamin H. Lok, et al.. (2016). Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT. Oral Oncology. 58. 27–31. 7 indexed citations

19.

Teckie, Sewit, Benjamin H. Lok, Shyam Rao, et al.. (2016). High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck. Oral Oncology. 60. 74–80. 12 indexed citations

20.

Lok, Benjamin H., M. Catherine Pietanza, Charles M. Rudin, et al.. (2015). The Factors Influencing the Utilization of Prophylactic Cranial Irradiation in Patients With Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). E420–E421. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact